Beckman Coulter Life Sciences, makes pharmaceutical and biopharmaceutical analysis faster and simpler with more robust data in today’s launch of the QbD1200+ Total Organic Carbon (TOC) Analyzer.

Beckman Coulter Diagnostics announced ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.

Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©. ToxTracker is an in vitro method that accurately predicts genotoxicity without the use of animals.

Partnership endorses mission to facilitate career progression and support life science industry growth.

New CRO system-level expansion elevates data stewardship and enables organizations to gain more insight with less oversight.

In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.

Company’s global professional services organization completes more than 100 successful customer go-lives within a single year.

The widespread use of artificial intelligence (AI) in medical decision-making tools has led to an update of the TRIPOD guidelines for reporting clinical prediction models. The new TRIPOD+AI guidelines are launched in the BMJ today.

Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.

Collaboration aims to provide researchers cutting-edge tools to enable transformational monitoring of key biomarkers in solid tissue transplants.